Heleen Dewitte

3.2k total citations · 1 hit paper
34 papers, 2.5k citations indexed

About

Heleen Dewitte is a scholar working on Molecular Biology, Immunology and Biomedical Engineering. According to data from OpenAlex, Heleen Dewitte has authored 34 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Immunology and 15 papers in Biomedical Engineering. Recurrent topics in Heleen Dewitte's work include RNA Interference and Gene Delivery (18 papers), Immunotherapy and Immune Responses (18 papers) and Ultrasound and Hyperthermia Applications (9 papers). Heleen Dewitte is often cited by papers focused on RNA Interference and Gene Delivery (18 papers), Immunotherapy and Immune Responses (18 papers) and Ultrasound and Hyperthermia Applications (9 papers). Heleen Dewitte collaborates with scholars based in Belgium, Netherlands and France. Heleen Dewitte's co-authors include Ine Lentacker, Stefaan C. De Smedt, Rein Verbeke, Karine Breckpot, Jitka Fučíková, Lucillia Bezu, Lorenzo Galluzzi, Oliver Kepp, Guido Kroemer and Radek Špíšek and has published in prestigious journals such as Advanced Materials, ACS Nano and Nature Nanotechnology.

In The Last Decade

Heleen Dewitte

33 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The dawn of mRNA vaccines: The COVID-19 case

2021 342 citations Rein Verbeke, Ine Lentacker et al. Journal of Controlled Release profile →

Peers

Countries citing papers authored by Heleen Dewitte

Since Specialization

Citations

This map shows the geographic impact of Heleen Dewitte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heleen Dewitte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heleen Dewitte more than expected).

Fields of papers citing papers by Heleen Dewitte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heleen Dewitte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heleen Dewitte. The network helps show where Heleen Dewitte may publish in the future.

Co-authorship network of co-authors of Heleen Dewitte

This figure shows the co-authorship network connecting the top 25 collaborators of Heleen Dewitte. A scholar is included among the top collaborators of Heleen Dewitte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heleen Dewitte. Heleen Dewitte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gompertz Model Use in Tumor Growth Curves Analysis 2023 ·SSRN Electronic Journal ·(unknown), (unknown), (unknown), Marleen Keyaerts, Heleen Dewitte, Rein Verbeke, Ine Lentacker, Karine Breckpot, Kurt Barbé	0
2	Transport by circulating myeloid cells drives liposomal accumulation in inflamed synovium 2023 ·Nature Nanotechnology ·Joke Deprez, Rein Verbeke, (unknown), (unknown), Heleen Dewitte, Tine Decruy, Julie Coudenys, Julie Van Duyse, Gert Van Isterdael, Dan Peer, Roy van der Meel, Stefaan C. De Smedt, Peggy Jacques, Dirk Elewaut, Ine Lentacker	20
3	Evaluation of Liposome-Loaded Microbubbles as a Theranostic Tool in a Murine Collagen-Induced Arthritis Model 2022 ·Scientia Pharmaceutica ·Joke Deprez, Silke Roovers, Guillaume Lajoinie, Heleen Dewitte, Tine Decruy, Julie Coudenys, Benedicte Descamps, Christian Vanhove, Michel Versluis, Dirk Elewaut, Peggy Jacques, Stefaan C. De Smedt, Ine Lentacker	1
4	Hydrogel‐Induced Cell Membrane Disruptions Enable Direct Cytosolic Delivery of Membrane‐Impermeable Cargo 2021 ·Advanced Materials ·Jelter Van Hoeck, (unknown), Aranit Harizaj, Glenn Goetgeluk, (unknown), Jing Liu, (unknown), Félix Sauvage, Herlinde De Keersmaecker, Christian Vanhove, Olivier G. de Jong, Pieter Vader, Heleen Dewitte, Bart Vandekerckhove, Kevin Braeckmans, Stefaan C. De Smedt, Koen Raemdonck	17
5	mRNA in cancer immunotherapy: beyond a source of antigen 2021 ·Molecular Cancer ·Lien Van Hoecke, Rein Verbeke, Heleen Dewitte, Ine Lentacker, Karim Vermaelen, Karine Breckpot, Sandra Van Lint	54
6	mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice 2020 ·Molecular Therapy — Nucleic Acids ·Lien Van Hoecke, Rein Verbeke, Dorien De Vlieger, Heleen Dewitte, Kenny Roose, (unknown), Olga Krysko, Claus Bachert, Bert Schepens, Ine Lentacker, Xavier Saelens	29
7	Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery 2020 ·Ultrasound in Medicine & Biology ·Klazina Kooiman, Silke Roovers, Simone A.G. Langeveld, Robert T. Kleven, Heleen Dewitte, Meaghan A. O’Reilly, Jean‐Michel Escoffre, Ayache Bouakaz, Martin D. Verweij, Kullervo Hynynen, Ine Lentacker, Eleanor Stride, Christy K. Holland	255
8	Non-viral delivery of chemically modified mRNA to the retina: Subretinal versus intravitreal administration 2019 ·Journal of Controlled Release ·Joke Devoldere, Karen Peynshaert, Heleen Dewitte, Christian Vanhove, Lies De Groef, Lieve Moons, (unknown), Deniz Dalkara, Stefaan C. De Smedt, Katrien Remaut	47
9	Enhancing Nucleic Acid Delivery with Ultrasound and Microbubbles 2019 ·Methods in molecular biology ·Heleen Dewitte, Silke Roovers, Stefaan C. De Smedt, Ine Lentacker	10
10	Sonoprinting of nanoparticle-loaded microbubbles: Unraveling the multi-timescale mechanism 2019 ·Biomaterials ·Silke Roovers, Guillaume Lajoinie, Ine De Cock, Toon Brans, Heleen Dewitte, Kevin Braeckmans, Michel Versluis, Stefaan C. De Smedt, Ine Lentacker	38
11	The obstacle course to the inner retina: Hyaluronic acid-coated lipoplexes cross the vitreous but fail to overcome the inner limiting membrane 2019 ·European Journal of Pharmaceutics and Biopharmaceutics ·Joke Devoldere, (unknown), Karen Peynshaert, Heleen Dewitte, Stefaan C. De Smedt, Katrien Remaut	21
12	Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA 2017 ·Journal of Controlled Release ·Rein Verbeke, Ine Lentacker, (unknown), Karine Breckpot, Mieke Van Bockstal, Benedicte Descamps, Christian Vanhove, Stefaan C. De Smedt, Heleen Dewitte	115
13	Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon 2016 ·Molecular Therapy — Nucleic Acids ·Katrijn Broos, Kevin Van der Jeught, Janik Puttemans, Cleo Goyvaerts, Carlo Heirman, Heleen Dewitte, Rein Verbeke, Ine Lentacker, Kris Thielemans, Karine Breckpot	89
14	Evading innate immunity in nonviral mRNA delivery: don’t shoot the messenger 2015 ·Drug Discovery Today ·Joke Devoldere, Heleen Dewitte, Stefaan C. De Smedt, Katrien Remaut	91
15	Choose your models wisely: How different murine bone marrow-derived dendritic cell protocols influence the success of nanoparticulate vaccines in vitro 2014 ·Journal of Controlled Release ·Heleen Dewitte, Rein Verbeke, Karine Breckpot, Roosmarijn E. Vandenbroucke, Claude Libert, Stefaan C. De Smedt, Ine Lentacker	13
16	The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy 2014 ·Journal of Controlled Release ·Heleen Dewitte, Sandra Van Lint, Carlo Heirman, Kris Thielemans, Stefaan C. De Smedt, Karine Breckpot, Ine Lentacker	105
17	The ReNAissanCe of mRNA-based cancer therapy 2014 ·Expert Review of Vaccines ·Sandra Van Lint, Dries Renmans, Katrijn Broos, Heleen Dewitte, Ine Lentacker, Carlo Heirman, Karine Breckpot, Kris Thielemans	68
18	Theranostic mRNA-loaded Microbubbles in the Lymphatics of Dogs: Implications for Drug Delivery 2014 ·Theranostics ·Heleen Dewitte, Katrien Vanderperren, Hendrik Haers, Emmelie Stock, Luc Duchateau, Myriam Hesta, Jimmy Saunders, Stefaan C. De Smedt, Ine Lentacker	53
19	Design and evaluation of theranostic perfluorocarbon particles for simultaneous antigen-loading and 19F-MRI tracking of dendritic cells 2013 ·Journal of Controlled Release ·Heleen Dewitte, Bart Geers, (unknown), Uwe Himmelreich, Jo Demeester, Stefaan C. De Smedt, Ine Lentacker	25
20	Crucial factors and emerging concepts in ultrasound-triggered drug delivery 2012 ·Journal of Controlled Release ·Bart Geers, Heleen Dewitte, Stefaan C. De Smedt, Ine Lentacker	104

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact